LIMERICK, Ireland, March 4, 2022 /CNW/ - kneat.com, inc.
(TSX: KSI) ("Kneat" or "the Company")
Limerick-based software company, Kneat, will announce today the
creation of up to 100 new jobs during the opening of its new 13,000
sq. ft green sustainable LEED GOLD standard office at Hawthorn
House in Limerick's National Technology Park.
The new positions will be focused on Sales & Marketing,
Research & Development, and Customer Success, bringing its
total number of staff to over 300.
The company, which develops cloud-based software solutions for
the Life Sciences industry, counts seven of the world's top ten
biopharmaceutical companies as customers. Founded in Limerick in
2007 by pharmaceutical and IT industry experts Eddie Ryan, Kevin
Fitzgerald and Brian Ahearne,
the company has seen record growth in recent years.
In a ceremony attended by Irish Taoiseach, Micheál Martin, and
Enterprise Ireland CEO, Leo Clancy,
the company's new 13,000 sq. ft. office at Hawthorn House will be
declared 'open for business' by Kneat Co-Founder and CEO
"As a Limerick man I have a deep connection to the people
and the city of Limerick, which is why I'm very happy to share the
news today that Kneat is announcing up to one-hundred new jobs to
be filled over the coming year", said Eddie
Ryan. "We are also very pleased to declare our new office at
Hawthorn House, open for business."
Today's jobs and new facility announcement are the latest in a
list of milestones for the growing business, which ranked third in
the Deloitte Technology Fast 50 Ireland Awards in December 2021. In November, the company up listed
from the Toronto Venture Exchange (TSXV) to the Toronto Stock
Exchange (TSX) and closed a Public Equity Financing of over
20 million Canadian dollars earlier
in the year.
Kneat, a Canadian company with operational headquarters in
Limerick, Ireland, develops and
markets the next generation Kneat Gx SaaS platform. Multiple
business work processes can be configured on the platform from
equipment to computer system validation, through to quality
document management. Kneat's software allows users to author,
review, approve, execute testing online, manage any exceptions, and
post approve final deliverables in a controlled FDA 21 CFR Part 11/
Eudralex Annex 11 compliant platform. Macro and micro report
dashboards enable powerful oversight into all systems, projects and
processes globally. Customer case studies are reporting
productivity improvements in excess of 100% and a higher data
integrity and compliance standard. For more information visit
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes "forward-looking
information" within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat's
business development activities, the use and implementation
timelines of Kneat's software within the customer's validation
processes, the ability and intent of the customer to scale the use
of Kneat's software within the customer's organization and the
compliance of Kneat's platform under regulatory audit and
inspection. While such forward-looking statements are expressed by
Kneat, as stated in this release, in good faith and believed by
Kneat to have a reasonable basis, they are subject to important
risks and uncertainties. As a result of these risks and
uncertainties, the events predicted in these forward-looking
statements may differ materially from actual results or events.
These forward-looking statements are not guarantees of future
performance, given that they involve risks and uncertainties.
The forward-looking information in this press release does not
include a full assessment or reflection of the unprecedented
impacts of the COVID-19 pandemic occurring since the first quarter
of 2020 and the ongoing and developing resulting indirect global
and regional economic impacts. This has resulted in significant
economic uncertainty and even though the Company has to date
experienced no significant impact to its operations, any potential
impact on our future is difficult to understand or measure at this
Kneat does not undertake any obligation to release publicly
revisions to any forward-looking statement, except as may be
required under applicable securities laws. Investors should not
assume that any lack of update to a previously issued
forward-looking statement constitutes a reaffirmation of that
statement. Continued reliance on forward-looking statements is at
an investors' own risk.
SOURCE kneat.com, inc.